Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
If you receive injections regularly, rotate the sites to prevent tissue damage
Both can be administered intranasally or subcutaneously and the reconstitution approach differs by route
Inflammatory bowel disease represents the most advanced clinical target, with at least one Phase II trial having examined a BPC-157-derivative compound (PL 14736) for ulcerative colitis, showing preliminary evidence of mucosal healing in human patients
It works systemically, not locally: Unlike BPC-157, which targets a specific injury site, TB-500 travels through the entire body and finds damaged tissue wherever it is, making it effective for diffuse or multi-site injuries
For professionals only
US$ 24.18
US$ 28.84
US$ 26.83
US$ 28.99
US$ 25.49
US$ 28.70
US$ 25.32
